Metrikler
Yayın
6
BM Sürdürülebilir Kalkınma Amaçları
Makaleler
Tümü (6)
SCI-E, SSCI, AHCI (5)
SCI-E, SSCI, AHCI, ESCI (5)
Scopus (6)
2023
20231. Epidemiology and risk factors of 28-day mortality of hospital-acquired bloodstream infection in Turkish intensive care units: a prospective observational cohort study
ASLAN A. T., Tabah A., KÖYLÜ B., Kalem A. K., AKSOY F., Erol Ç., et al.
The Journal of antimicrobial chemotherapy
, cilt.78, sa.7, ss.1757-1768, 2023 (SCI-Expanded, Scopus)
2022
20222. Pazopanib-induced chylothorax in a patient with renal cell carcinoma
KÖYLÜ B., TEKİN F., AKTAŞ B. Y., KILIÇKAP S., KÖKSAL D.
ANTI-CANCER DRUGS
, cilt.33, sa.1, 2022 (SCI-Expanded, Scopus)
2022
20223. Adjuvant treatment with paclitaxel plus trastuzumab for node-negative breast cancer: real-life experience
Diker O., AKTAŞ B. Y., Ak R., KÖYLÜ B., BAŞ O., TABAN H., et al.
FUTURE ONCOLOGY
, cilt.18, ss.323-331, 2022 (SCI-Expanded, Scopus)
2021
20214. A NEW SCORING SYSTEM COMPOSED OF MMP-1, AST/ALT RATIO AND TOTAL METABOLIC SYNDROME SCORE CAN DETECT AT-RISK NASH PATIENTS WITH FIBROSIS STAGE >= 2 MORE ACCURATELY THAN FIB-4 SCORE, NAFLD FIBROSIS SCORE, BARD SCORE, APRI SCORE AND MR ELASTOGRAPHY
KÖYLÜ B., SÖKMENSÜER C., KESKİN O.
HEPATOLOGY
, cilt.74, 2021 (SCI-Expanded, Scopus)
2021
20215. Adjuvant treatment with paclitaxel plus trastuzumab for node negative human epidermal growth factor receptor 2-positive breast cancer: Real life experience
Diker O., AKTAŞ B. Y., Ak R., KÖYLÜ B., BAŞ O., Olgun P., et al.
CANCER RESEARCH
, cilt.81, sa.4, 2021 (SCI-Expanded, Scopus)
2015
20156. İnternlerin Gözünden HPV Enfeksiyonları ve HPV Aşısı
Çeşmeci Y., Köylü B., Sancak E., Baki H. E., Sulaiman J., Şenel S., et al.
Türk Jinekolojik Onkoloji Dergisi , cilt.18, sa.3, ss.85-92, 2015 (Scopus)